Search Results for "Infusion Therapy Home Infusion Companies"

10:51 EDT 21st October 2016 | BioPortfolio

Matching Channels

Intraosseous Infusion

CD20 Antibodies

The chimeric anti-CD20 antibody rituximab (Rituxan & MabThera) from Biogen Idec and Genentech/Roche is one of the world’s commercially most successful antibodies (2007 sales of over US$ 5 bl...

Lysosomal storage disorders (LSDs)

Lysosomal storage disorders (LSDs) represent a group of about 50 genetic disorders caused by deficiencies of lysosomal proteins. Most involve genetic mutations causing loss of function of key catabo...


The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...


In addition to the Silicon Valley, California on the west coast of the USA is home to a biotechnology hub. 26% of all American biotechnology firms are located in this state, but they count for over ...

Matching News

Home Infusion Therapy for Cellulitis: The Next Fad, or a Solid Option?

A retrospective study of a single center's experiment with home infusion therapy for cellulitis raises as many questions as it answers.

Five Key Takeaways from the New 2016 Infusion Therapy Standards of Practice

Earlier this year, one of the most widely used resources guiding clinical practice for the infusion specialty received a major upgrade. The Infusion Nurses Society (INS) issued a revised Infusion Ther...

CVS Study Shows that Home Infusion Care Improves Patient Outcomes and QOL While Reducing Costs

WOONSOCKET, R.I., May 4, 2016 /PRNewswire/ — A new study by the CVS Health Research Institute found that home infusion care is safe, clinically effective and improves quality of life while reduc...

ICU Medical to acquire the Hospira Infusion Systems Business from Pfizer for $1B

ICU Medical will acquire all of Pfizer’s global infusion therapy business, Hospira Infusion Systems (HIS), for $1 billion in cash and stock. The Hospira Infusion Systems business includes IV pumps, ...

Home infusion patient satisfaction to be studied

Following through on an initiative announced at its 2016 annual meeting (New Orleans, March 21-24), the National Home Infusion Foundation has launched a “patient satisfaction survey” study. Th...

CVS Health Research Institute: Home infusion both economically and clinically viable

Michael JohnsenThe findings underscore the value of home infusion services – where medication is delivered intravenously in a patient's home – for the health care system, including pat...

ICU Medical buys Hospira's infusion therapy business from Pfizer

Seeking to become a leading global pure play infusion therapy firm, ICU Medical Inc. is paying $1bn--$400mm in its stock and $600mm in cash--to acquire Pfizer Inc.’s Hospira Infusion Systems busines...

ICU Medical to buy Pfizer's infusion therapy business for $1 bln

Oct 6 (Reuters) - Medical device maker ICU Medical Inc said it would buy Pfizer Inc's global infusion therapy business, Hospira Infusion Systems (HIS), for $1 billion in cash and stock.

Matching PubMed Articles

The Role of Unlicensed Assistive Personnel in the Provision of Infusion Therapy.

Infusion Standards: A Document Without Borders.

Home infusion of intravenous velaglucerase alfa: Experience from pooled clinical studies in 104 patients with type 1 Gaucher disease.

The introduction of a home therapy option during clinical trials of velaglucerase alfa in patients with type 1 Gaucher disease marked the first time that home infusions have been permitted during a cl...

How to promote the respect of good infusion practices by meeting health care professionals?

Health care professionals often forget that there are risks associated with infusion therapy even if it is a common care. In order to assess this practice and to draw potential improvement actions, an...

Infusion Rate Dependent Pharmacokinetics of Bendamustine with Altered Formation of γ-hydroxybendamustine (M3) Metabolite Following 30- and 60-min Infusion of Bendamustine in Rats.

Bendamustine is an alkylating agent administered as 1 h intravenous infusion in the clinic for the treatment of malignant haematological cancers. The aim of the study was to evaluate the pharmacokin...

Search Whole site using Google

Quick Search
Advertisement Advertisement